Request Deal Involvement
Janus Henderson Investors, Brahma Capital and BioTrack Capital led a $84m Series B funding round in BlossomHill Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Cooley
or
Principals
target
BLOSSOMHILL THERAPEUTICS INC
bidder
JANUS HENDERSON INVESTORS
bidder
BRAHMA CAPITAL
bidder
BIOTRACK CAPITAL
bidder
CORMORANT ASSET MANAGEMENT
bidder
ORBIMED ADVISORS LLC
bidder
PLAISANCE CAPITAL MANAGEMENT LLC
bidder
VIVO CAPITAL LLC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2026 Datasite